Genmab — December 2017

[bongobob]

Patent på CD3xCD20 http://www.freshpatents.com/-dt20171214ptan20170355767.php

[bongobob]

Indsendt i januar, lidt sent når man tænker på at Novartis aftalen er fra 2015.

[bibob]

God morgen.

[JørgenVarnæs]

Mornings! Mon ikke der er sendt IND ansøgning på cd3cd20 nu? Har vi i øvrigt fået target på den? Var der ikke tale om noget autoimmunt også?

[E_L]

Bold move by Janssen to go to court in Sweden?

[rex_pacis]

didn't know you could sue states for not buying your products

[rex_pacis]

I don't know much about Swedish law though... Hope we win!

[rex_pacis]

they don't go to court yet @EL they have only complained about the decision

[E_L]

ok rex, thks, i was a bit surprised already

[Parasitism]

http://client2.mailmailmail.net/display.php?M=29924507&C=4fc26eeae080d17f77834637f9601330&L=4942&N=46994&S=228599&utm_source=MailPlatform&utm_medium=email&utm_campaign=Danske+Akiter+-+11.+udgave+2017

[Parasitism]

Se under flyvere i linket

[E_L]

tweetchat Transcript, on SMM, seems ASCENT trial will start Q1 18 - https://www.symplur.com/healthcare-hashtags/MMSM/transcript/?hashtag=MMSM&fdate=12%2F20%2F2017&shour=13&smin=0&tdate=12%2F20%2F2017&thour=14&tmin=0

[bibob]

Thanks E L. Looks like ASCENT will be the new trial in focus. !!

[polle1]

@bibob : hvad er ASCENT ?

[Bulder]

Det har været længe undervejs. Været "på trapperne" i 1½ år nu. http://bsri.myeloma.org/ascent-trial/

[JKY_VH]

Forholdene omkring infusionen af Darzalex er nu så sikre, at Vejle nu nedsætter infusionstiden fra 3,5 timer til 1,5 timer. Darzalex viser dermed endnu en gang sin unikke konkurrencekraft.

[Bulder]

Men kun fra 3. infusion ? formentlig

[JKY_VH]

det er jeg ikke helt klar over pt.

[Bulder]

Men nu er Ascent da i det mindste på CT: https://www.clinicaltrials.gov/ct2/show/NCT03289299?term=ascent+daratumumab&rank=1

[E_L]

that is great JKY, that is the 90 minutes we heard at ASH